Verseau Therapeutics Announces FDA Clearance of Investigational New Drug Application for VTX-0811, a PSGL-1 Monoclonal Antibody Read more
Genprex Receives FDA Fast Track Designation for REQORSA Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer Read more
Pfizer and BioNTech Receive FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older Read more
WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody Read more
Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine Read more
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO (selinexor) in Europe and Other Key Global Territories Read more